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Summary 
The c-fes  protooncogene is  expressed at  high levels in  the  terminal stages  of granulocytic 
differentiation, but so far no definite function has been attributed to the product of this oncogene. 
To tackle this problem, the c-Jbs protooncogene expression has been inhibited in HL60 cells, 
and fresh leukemic promyelocytes of acute promyelocytic leukemia have been induced to differentiate 
with retinoic acid (RA) and dimethylsulfoxide (DMSO). Inhibition was obtained by incubating 
the cells with a specific c-Jbs antisense oligodeoxynucleotide.  It was observed that the cells, rather 
than differentiating, underwent premature cell death showing the morphological and molecular 
characteristics of apoptosis. This process was inhibited by granulocyte and granulocyte/macrophage 
colony-stimulating factor, but not by interleukin 3 (IL-3), IL-6, or stem cell factor. Our present 
results demonstrate that the loss of cell viability that occurs during the in vitro differentiation 
of myeloid cells, after the complete inhibition of the c-Jbs gene product and treatment with RA- 
DMSO, is due to activation  of programmed cell death. It is concluded that a possible role of 
the c-Jbs gene product is to exert an antiapoptotic effect during granulocytic differentiation. 
T 
he c-Jbs protooncogene is the cellular equivalent of the 
v-Jes, the transforming oncogene of the Snyder-Theilen 
feline sarcoma virus (1, 2). This gene has been mapped on 
chromosome 15q25-26 (3) and the complete sequence of the 
genetic locus has been reported (4-6). The gene codes for 
a tyrosine kinase protein, the p92  :-feS (7),  that  forms,  to- 
gether with the c-abl product, the family of the cytoplasmic 
tyrosine kinases (8). The 5' region of this gene is unique when 
compared with  the other tyrosine kinases  of the src  and 
receptors gene family (9, 8). In spite of its localization near 
the breakpoint of the t(15;17), characteristic  of the acute 
promyelocytic leukemia (APL), 1 the c-Jes oncogene is not in- 
volved in this specific translocation  (10, 11). Previous studies 
in our laboratories  did not show any alteration  of the c-Jbs 
gene locus in the HL60 myeloid cell line as well, which has 
1 Abbreviations used in this paper: APL, acute promyelocytic leukemia; AS, 
antisense;  DP, direct primer; RA, retinoic acid; ILP, reverse primer; S, 
sense; SCF,  stem cell factor;  Vit. D3,  la, 25-dihydroxyvitamin D3. 
been accurately screened before our expression studies. These 
studies have shown that the c-Jbs mRNA is detectable at a 
considerable level in myeloid proliferating cells, and that the 
level of expression increases during the terminal differentia- 
tion to granulocytes and, though at lower level, to mono- 
cytes (12-14). Other studies have shown that the c-Jbs gene 
product, the p92 c-fes protein, is detectable only in myeloid 
cells (15-18). To tackle the problem of the specific function 
of this gene in myeloid differentiation, we have inhibited the 
expression of the c-Jes protooncogene in HL60 cells induced 
to differentiate with retinoic acid (R.A) and DMSO, using 
the methodology of antisense oligodeoxynucleotides (19, 20). 
Our results showed that HL60 cells treated for 5 d with c-Jbs 
antisense (AS) oligomer and induced to differentiate with RA 
and DMSO undergo to progressive cell death (21). Rather 
than reaching the morphology of terminally differentiated 
granulocytic cells, the AS-treated cells retain their immature 
phenotype and begin to die after 15 h of treatment with the 
granulocytic differentiation inducers. After 4 d of this treat- 
ment, >90% of HL60 cells are dead, showing pycnosis and 
karyorrhexis. These morphological aspects suggest that the 
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rather than the consequences of a toxic effect of the AS treat- 
ment (22, 23). In fact, the same c-Jes AS oligomer does not 
have any toxic effect on the HL60 cells induced to differen- 
tiate to monocytes or macrophages by la, 25-dihydroxyvitamin 
D3 (Vit. D3) or tumor-promoting activity (TPA) (21). A 
set of experiments was therefore planned to characterize this 
cell death. Besides the morphology of the calls, apoptosis is 
characterized by a typical pattern of cleavage of DNA into 
integer multiples of ",,200-bp  fragments, a length roughly 
corresponding to the amount of  DNA in one nucleosome unit 
(24). Furthermore, apoptosis has been found to be inhibited 
by several survival  factors  (25),  which in the hemopoietic 
system are mairtly growth factors such as IL-3, GM-CSF, IL-6, 
and G-CSF (26).  The dependence of the apoptotic process 
on protein synthesis has been shown in HL60 cells, where 
cycloheximide  induces large scale apoptosis (27). Our results 
indicate that both in HL60 calls and in freshly collected leu- 
kemic promyelocytes the inhibition of c-J~s expression  after 
induction to granulocytic differentiation leads to the activa- 
tion of nuclear events  underlying programmed cell death. 
Materials  and Methods 
Cell Cultures.  HL60 cells were cultured in 24-well tissue cul- 
ture plates. Each well contained 7  x  10  s cells/m1 in RPMI 1640 
supplemented with 10% heat-inactivated FCS and 2 mM t-glut- 
amine. Highly homogeneous leukemic  blast cells, obtained by bone 
marrow biopsy of a patient with APL, M3 phenotype carrying 
the t(15;17), were cultured in the same medium. Differentiation 
was induced by addition of I/zM RA plus 1% DMSO. In these 
culture conditions, terminal differentiation was obtained after 5 d 
(21). Morphology was assayed  by cytocentrifugation followed by 
May Grunwald Giemsa (MGG) staining. Cytochemical reactions 
for naphthol-AS-D-chloroacetate  esterase, a-naphthyl acetate esterase, 
and myeloperoxidase  were performed by standards methods (28, 
29). Purified peripheral blood granulocytes or mononuclear cells 
were used as positive controls for cytochemical assays. 
Synthesis and Purification of Oligomers.  Nonmodified deoxy- 
ribonucleotides were  synthesized on an  automated  solid-phase 
synthesizer (381A; Applied Biosystems  Inc.) by standard b-cyano- 
ethyl-phosphoramidite chemistry, extracted several times  with 
ammonium-hydroxide and ethanol precipitated as described (30). 
All oligomers were lyophilized and suspended directly in cell cul- 
ture medium. The sequences of synthesized oligomers and their 
relationship to the organization of c-~s coding regions (4, 5) are 
shown in Table 1. Homology between the oligomers  and the human 
sequences present in the GenBank data bank was no greater than 
70%. Furthermore, the 5' region of the c-~s protooncogene, where 
the AS oligonucleotide was selected, can be considered unique (1, 
5). In fact, comparison with sequences of the genes encoding sev- 
eral protein kinases, particularly the tyrosine kinases belonging to 
the src family, revealed a low degree of homology (8, 9). 
Determination of Oligodeoxynucleotides Stability.  All the experi- 
ments were performed with a single lot of  FCS that had been inac- 
tivated at 65~  for 20 min, and selected for minimal nuclease ac- 
tivity Low specific radioactivity 3zp end-labeled (31) oligomers 
were added to the medium at a final concentration of 10/~M and 
incubated  for 24, 48, 72, and 96 h at 37~  Integrity of  the oligomers 
was evaluated  by PAGE. We selected  a serum in which the oligode- 
oxynucleotides were stable for >24 h. 
Delivery System  of the  c-fes Oligomers into Proliferating HL60 
Cells.  HL60 and fresh leukemic blast cells express high levels of 
transferrin receptor. We used in our experiments a delivery system 
based on receptor-mediated endocytosis to  introduce  the  c-~s 
oligomers complexed with transferrin-polylysine conjugate into 
HL60 cells  as described  (32). With this delivery  system  the oligomer 
uptake e~ciency was, in our hands, •10  times higher as compared 
with noncomplexed oligomers. The uptake efficiency  was evalu- 
ated as described (33). The DNA/RNA duplex resistant to $1 
nuclease digestion was detected 4 and 24 h after culture of HL60 
cells in  the presence of labeled c-~s AS oligomer-transferrin- 
polylysine complex as described (21). 
Oligomer Treatment of the Cells.  c-Jes  sense (S) or AS oligomers 
were added to the cultures every  24 h to maintain a final concentra- 
tion of ,'~10-15/~M. Control cultures were left untreated. After 
3 d of oligomer treatment the culture medium was replaced with 
fresh medium, containing 10/zM c-~s S or AS oligomer. After 
120 h of  oligomer treatment ILA-DMSO  was added to the cultures 
at the indicated concentration. The experimental conditions and 
incubation period for these inducers are detailed  elsewhere (34, 35). 
Recombinant human growth factors were added to different cell 
cultures after the inactivation of the c-fis gene product at the fol- 
lowing concentrations:  ID3 (5 ng/ml; Genzyme  Corp., Cambridge, 
MA), IL-6 (10 U/ml; Sigma Chemical Co., St. Louis, MO), stem 
cell factor (SCF) (10 ng/ml; Genzyme Corp.), GM-CSF (20 ng/ml; 
Genzyme Corp.), G-CSF (1,000 U/ml; British Biotechnology  Ltd., 
Cowley, Oxford, UK). The cytokines were added simultaneously 
with the differentiation inducers and in the presence of 10/~M of 
c-~s S or AS oligomers. 
Detection of c-fes mRNA in HL60 Cells Untreated and Treated with 
c-fes or AS Oligomer.  Total  cellular RNA was extracted from 7 
x  10  s HL60 cells exposed to c-fis oligomers for 120 h and from 
untreated cells, in the presence of 10/zg ofEscherichia coti tRNA, 
using a modification of the guanidinium isothiocyanate  procedure 
(36). RNA was then reverse transcribed using 400 U of murine 
Moloney leukemia  virus reverse transcriptase (MuLV  R'I~ BRL Life 
Technologies Inc., Gaithersburg, MD) and 0.5 #g of c-J~s reverse 
primer (RP) oligomer for 1 h at 37~  in lx  RT-PCR buffer (10 
mM Tris, pH 8.3, 50 mM KC1, 1 mM MgClz, 10 mM DTT, 200 
~M dATP, dCTP, dGTP, dTTP). The oligomers used in the RT- 
PCR reaction are reported in Table 1. The resulting specific  eDNA 
fragments were amplified with 3 U of Taq polymerase (Promega 
Biotec, Madison, WI) in the presence of  0.5/~g of  c-fis  direct primer 
(DP) oligomer in lx  RT-PCR buffer. Thus, a 258-bp fragment 
corresponding to the c-~s coding region, nucleotides (nt) 163-574 
of the genetic locus, was generated during 35 cycles  of PCR (94~ 
for 40 s, annealing at 50~  for 2 min, and at 72~  for 4 min). 
50/~1 of the 100/~1 PCR volume was separated on a 4% Nusieve 
(FMC-Bio Products, Rockland, ME) agarose gel and transferred 
by the electroblotting procedure (37) to a Gene Screen membrane 
(NEN-DuPont, Boston, MA). The synthetic oligomer probe was 
end-labeled with 3,-[3~p]ATP by polynucleotide  kinase as described 
(31). Blots were hybridized with a c-fes oligomer probe, using the 
experimental  condition described  by Albretsen et al. (38). As a con- 
trol for the amount of RNA used as substrate, oligomers specific 
for  the B2-microglobulin eDNA  (39) were used, in  a parallel 
amplification reaction. 
Determination of Growth Rate and DNA Content of ilL60 Cells 
after 120 h of Oligomer Treatment.  The HL60 cell line has a dou- 
bling time of 23 h and a low rate of spontaneous differentiation 
(<5%). The DNA content of untreated and oligomer-treated cells 
was determined by flow cytometry according to Dolbeare et al. 
(40) using a FACScan  |  (Becton Dickinson & Co., Mountain View, 
382  Antiapoptotic  Effect of c-~s during Gr~nulocytic  Differentiation CA) equipped with a single 488-nM argon laser. Briefly, 106 cells 
were incubated in cell culture medium with 10 #M bromodeoxy- 
uridine (BrdU) (Sigma Chemical Co.) at 37~  for 30 min. A mouse 
mAb  against  BrdU  (anti-BrdU;  Becton Dickinson &  Co.) was 
bound to BrdU incorporated into neosynthesized DNA. The com- 
plex was detected by a rabbit fluorescent anti-FC antibody (Dako 
Patts A/S, Glostmp, Denmark). DNA histograms were generated 
from 70% ethanol-fixed and RNase-treated (1 mg/ml) cells. Cells 
were stained with propidium iodide (PI) (50 #g/ml) and analyzed 
using the DNA cell cycle analysis program (C-12/86). Every 24 h, 
for 5 d, at least  104 cells were subjected to replicate analysis with 
<5% standard error. Viability,  determined by the trypan blue ex- 
clusion test, in untreated and oligomer-treated cultures after 5 d 
of growth was 90-95 %. Experiments were repeated several times. 
Measure of HL60  Apoptosis by PI Staining and Flow Cytora- 
etry.  The 200 g centrifuged pellet (5  x  10  s cells) was suspended 
in 500 #1 of hypotonic fluorochrome solution (50 #g/ml PI, 0.1% 
sodium citrate, 0.1% Triton X-100).  The samples were placed at 
4~  in the dark at least 30 rain before the flow cytometric analysis 
(41),  performed with a FACScan  |  (Becton Dickinson & Co.). 
DNA Extraction and Analysis of  DNA Fragmentation.  DNA ex- 
traction was performed using a modification of the technique de- 
scribed by Gross-Bellard  et al. (42). Briefly, the cells were pelleted 
and washed twice in PBS. The pellet was suspended in 0.4 #1 of 
SEDTA (0.1 M NaC1,  50 mM NazEDTA,  pH 7.8) containing 33 
gl of 10 mg/ml proteinase K and 40 #1 of 10% SDS. The lysate 
was incubated for at least 4 h at 37~  then extracted once with 
1 vol of SEEYT_A  saturated phenol and 1 vol of CIA (2% isoamyl 
alcohol in chloroform). The supernatant was precipitated overnight 
at  - 20~  with 40 #1 of 3 M  Na acetate,  pH 5,  15/~g of E. coli 
tRNA, and 2.5 vol of  cold 100% ethanol The pellet was suspended 
in 0.4 ml of lx  TE buffer (10 mM Tris,  1 mM NazEDTA,  pH 
8), then 1 #1 of 10 mg/ml DNase-free RNAse was added, and the 
suspension was incubated for 15 min at 37~  A second digestion 
with proteinase K was carried out for 1 h  at 37~  with 100 gl 
of proteinase K in SEDTA (1 ml of 10 mg/ml proteinase K  and 
9 ml of SEDTA) after addition of 10 #1 of 10% SDS. The DNA 
suspension was then extracted once with 0.5 ml of 1:1 phenol/chlo- 
roform isoamyl alcohol (CIA), and the supernatant was precipi- 
tated as before. The pellet, after washing with 70% ethanol, was 
vacuum dried and suspended in 50/A of lx TE buffer. DNA samples 
were then separated  on 1.2% agarose gd in TBE buffer (90 mM 
Tris borate, 90 mM boric add, 2 mM EDTA) containing I mg/ml 
ethidium bromide. 
Figure  1.  Detection by RT-PCP, of the c-~s mRNA in HL60 cells 
treated with the c-fis AS oligomer for the time indicated. Total cellular 
RNA was extracted every 24 h for a period of 4 d after c-fis AS oligomer 
treatment as described in Materials and Methods. The 258-bp amplified 
fragment was obtained using the DP1 sequence  and RP oligomers.  A very 
similar pattern was obtained using the DP2 sequence  oligomer giving an 
amplified fragment of 108 bp. Bz-microglobulin  expression  served  as con- 
trol. The oligodeoxynucleotides  primers and probes used in the P,T-PCR 
reaction are reported in Table 1. 
Results 
Treatment of  Proliferating HL60 Cells with a Specific c-fes AS 
Oligomer and Differentiation Inducers.  As shown in Fig. 1, after 
96  h  of treatment  with  the  c-fis AS  oligomer,  the  corre- 
sponding mRNA is not detectable by the RT-PCR technique. 
However cell growth does not appear to be modified, since 
the proportion  of cells in G1,  S,  and G2 phases  of the cell 
cycle is not altered by antisense treatment  (Fig.  2)  and  the 
cell doubling time is 23 h, i.e., the same observed in untreated 
and c-fis S oligomer-treated HL60 cells (data not  shown). 
The differentiation of HL60 cells is also not modified after 
the disappearance  of c-.~s  mP,  NA when TPA and Vit.  D3 
are used as inducers,  although  the TPA-treated cells  show 
a reduced adherence capability. On the contrary, a completely 
different result is obtained when the c-~s AS oligomer-treated 
Table  1.  Nucleotide Sequences of Oligomers Used in the Antisense Strategy and in the R T-PCR Reaction 
Gene  Deoxynucleotide sequence (5'-3')  Region  Mer  Amplified DNA  fragment 
s 
c-fes AS 
c-fes DP1 
c-fes DP2 
c-fes R.P 
c-fes probe 
B2-microglobulin DP 
B2-microglobulin RP 
B2-microglobulin probe 
GGCTTCTCTTCCGAGCTG  163-180  18 
CAGCTCGGAAGAGAAGCC  163-180  18 
GGCTTCTCTTCCGAGCTG  163-180  18 
TCCCTGCAGGACAGTGGG  313-330  18 
CAGCAAGCGGTTCAGGCC  55%574  18 
TCCTGGGCTGAGATCACCAGCCAAACTGAG  525-554  30 
CTCGCGCTACTCTCTCTTTCT  1-21  21 
TCCATTCTTCAGTAAGTCAACT  141-162  22 
CAGGTTTACTCACGTCATCCAGCAGAGAAT  55-84  30 
258 
108 
162 
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Figure 2.  Effect of the c-~s S and AS oligomers on the distribution 
of HL60 cells among the different cell cycle phases after 120 h of incuba- 
tion. Untreated cells are also reported. The doubling time of HL60 cells 
in the presence ors or AS c-fis oligomers was ",23 h, not unlike the dou- 
bling time of untreated HL60 cells. 
Table  2.  Effect of the c-fes AS  Oligomer  Treatment of the 
HL60  Cells on the 2C/4C  Ratio after 24 and 48 h of 
Differentiation Induction 
Time  Sense  Antisense  Control 
24  h  4,1  17,4  2,4 
48  h  3,2  11,5  2,3 
cells are induced to granulocytic differentiation by RA-DMSO. 
Albeit maintaining their immature characteristics,  the cells 
begin  to die after a few hours,  and >70%  of cell death is 
observed after 48 h (Fig. 3). No evidence of morphological 
and functional granulocytic differentiation was ever observed 
before apoptotic death.  This  appears to exclude the possi- 
bility that antisense treatment merely accelerates the differen- 
tiation process. It is worthwhile to point out that the evalua- 
tion of the 2c/4c ratio indicates  that at 24 and 48 h of c-)~s 
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Figure  3.  DNA fluorescence of PI-stained HL60 cells after 24 and 48 h 
of incubation under different experimental conditions. DNA histograms 
(log scale) of HL60 cells induced to differentiate with RA-DMSO (A and 
B),  in presence of c-~s S oligomer (C and D) or c-~s AS oligomer (E 
and F), for 24 (left)  and 48 h (right). 
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Figure 4.  DNA fluorescence of H-stained leukemic promyeiocytes of 
APL after 24 and 96 h of incubation under different experimental condi- 
tions. DNA histograms (log scale) of APL cells induced to differentiate 
with RA-DMSO (A and B), in presence of c-fis S oligomer (C and D) 
or c-~s AS oligomer (/7 and F), for 24 (left) and 96 h (right). 
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tion  of cells  in  the  G~ phase of the cell cycle (Table 2). 
Effects of c-fes AS  Oligomer and Differentiation Inducers on 
Fresh Leukemic Promyelocytes of APL,  On  fresh leukemic 
promyelocytes of APL, the treatment with c-Jbs AS oligomer 
and differentiation inducers has an effect very similar to that 
observed in HL60 cells.  As shown in Fig. 4,  ~90%  of the 
cells die after 4 d, whereas 40-60% of the untreated or S-treated 
cells  are still  alive. 
Morphological and Molecular Characteristics of the HL60 Cell 
Death  after  Treatment with c-fes AS Oligomer and Induction to 
Granulocytic Differentiation.  As shown in Fig. 5, the cell death 
is characterized by premature  pycnosis followed by karyor- 
rhexis without lysis of the cell. DNA double-strand cleavage 
produces fragments of'~ 185-200 bp, synchronously with the 
compaction  of chromatin  observed morphologically.  This 
DNA ladder pattern is evident in the DNA extracted after 
24  and  48  h  of treatment  with  RA-DMSO  and  c-]bs AS 
oligomer (Fig. 6). On the contrary, high molecular weight 
DNA is found in HL60 cells treated with the differentiation 
inducers  alone  or in  association with  c-Jbs S oligomer. 
Protective Effects of  Hernopoietic Growth Factors on Cell Death 
Induced by Inhibition of c-fes Gene Expression  in RA-DMSO- 
treated HL60 Cells.  As previously reported, IL-3, IL-6, SCF, 
GM-CSF, and G-CSF were tested to examine their capability 
to compete with the apoptotic process induced by the inhi- 
bition of c-Jbs gene expression during granulocytic differen- 
tiation.  The  cytofluorometric  analysis,  carried  out by the 
method described above, shows that II.-3, IL-6, and SCF have 
no protective effect (Fig.  7).  A  quite different result is ob- 
served when GM-CSF and G-CSF are added to the cell cul- 
tures (Fig.  8). As summarized in Fig. 9,  ,,o70% of the cells 
are protected both by GM-CSF and G-CSF, and the protec- 
tion lasts for >3 d,  since at  120 h of culture,  >40%  of the 
cells are still alive. Each experiment was repeated three times, 
and the variability was never >10%. On the contrary, treat- 
ment with IL-3, IL-6, and SCF does not result in any protec- 
tive effect. Table 3 shows that 1L-3, IL-6, and SCF are unable 
to avoid the increase of the 2c/4c ratio, although this increase 
is delayed. G-CSF and GM-CSF, on the contrary, leave this 
ratio unmodified and very similar to controls. These results 
confirm that an early consequence of the induction of apop- 
tosis is  the increase in  the  2c/4c ratio. 
Discussion 
In this work we demonstrate that the loss of cell viability 
that occurs during the in vitro differentiation of myeloid cells, 
after the complete inhibition of the c-Jbs gene expression and 
treatment  with  RA-DMSO,  is  due  to  activation  of pro- 
Figure  5.  Morphological  characteristics of HL60 cell death after treatment with c-~s AS oligomer and induction to granulocytic differentiation. 
(A) Proliferating HL60 cells after 5 d of treatment with c-Jbs  antisense oligomer; (B) terminal differentiation with granulocytic  morphology observed 
when the HL60 are induced to differentiate  with RA-DMSO for 5 d; (C) terminal differentiation with granulocytic  morphology  observed  when HL60 
cells, pretreated for 5 d with c-jbs  S oligomer, are induced to differentiate with RA-DMSO for 5 d in presence of the same concentration of c-Jbs  S 
oligomer; (D-F) progressive  cell death of HL60 cells induced to differentiate with RA-DMSO in presence of c-fes AS oligomer for 24 (D), 48 (E) 
and 96 h (F).  x 770. 
385  Manfredini  et al. Figure  6.  Agarose  gel dectrophoresis  of  DNA recovered  from untreated 
and c-fis oligomer-treated HL60 cells. Lane 1, X phage DNA digested 
with restriction endonucleases  EcoRI  and HindIII  (DNA molecular  weight 
marker lIl; Boehringer, Mannheim, Germany); lane 2, high molecular 
weight DNA extracted  from proliferating HL60  cells; lanes 3 and 4, high 
molecular weight DNA extracted from HL60 cells induced to differen- 
tiate with RA-DMSO for 24 and 48 h, respectively,  in the presence of 
c-fis S oligomer; lanes 5 and 6, fragmented DNA extracted from HL60 
cells induced to differentiate with RA-DMSO for 24 and 48 h, respec- 
tively, in the presence  ofc-fis AS oligomer; lane 7, pBR328  digested  with 
restriction endonucleases  BglI and HinfI (DNA molecular  weight marker 
VI; Boehringer). 
grammed cell death rather than to an accelerated cell differen- 
tiation. In fact, cytospins prepared at several different intervals 
from 24 to 96 h of c-Jbs AS oligomer and inducers treatment 
never show the presence of cells with differentiated granulo- 
cytic morphology.  Cytochemical studies  (data not  shown) 
have  not allowed us to obtain any evidence of progress to- 
ward granulocytic or monocytic differentiation.  The  mor- 
phological and molecular aspects of the effect of c-Jbs inhibi- 
tion in HL60 differentiating cells suggest that the precocious 
cell death is the consequence of an apoptotic process. Strong 
support for this conclusion is brought by the observation that 
GM-CSF and G-CSF promote cell survival in differentiating 
HL60 cells by interfering with the inactivation  of the c-Jbs 
proto-oncogene and thus suppressing apoptosis (43, 44). The 
molecular mechanism involved in the apoptotic process in- 
duced by c-Jbs inhibition  needs to be identified.  The apop- 
totic cell death is induced very early during the granulocytic 
differentiation  of myeloid cells  treated  with  the  AS  c-Jbs 
oligomer, occurring largely 24-48 h after the differentiation 
induction.  HL60  cells undergo spontaneous apoptosis after 
terminal differentiation  at least 6 d after RA-DMSO treat- 
ment (45). Normal neutrophils also undergo apoptosis during 
inflammation,  and it seems possible to conclude that  apop- 
tosis represents the physiological way of death in these cells 
(46). In our experimental conditions, an important question 
is represented by the functional state of the cells involved in 
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Figure  7.  DNA fluorescence  ofPI-stained HL60 cells  after 24 and 48 h 
of incubation under different experimental  conditions. DNA histograms 
(log scale)  of HL60 cells  induced  to differentiate  with RA-DMSO in pres- 
ence of c-fis AS oligomer and treated with IL-3 (,4 and B), Ib6 (C and 
/9), and SCF (E and F) for 24 (left) and 48 h (right). 
the process. In fact the function of the c-Jbs product seems 
to occur mainly in granulocytic cells out of cycle, since the 
c-Jbs mRNA has been detected in increasing amounts in the 
terminal stages of granulocytic differentiation (12-14).  Fur- 
thermore,  no effect on cell proliferation  has been observed 
by the AS treatment  of proliferating HL60 cells.  The GM- 
CSF and G-CSF have no inhibitory effect on the growth of 
HL60 cells and no enhancing effect on differentiation  (47). 
Therefore the protective effect of G-CSF and GM-CSF is pre- 
sumably related to events occurring in the short period when 
the cells, still in cycle, are drawn to terminal differentiation. 
The observation that at 24-48 h of AS c-Jbs treatment  there 
is a sharp decrease in the proportion of 4c cells suggests that, 
as shown in other experimental systems (48), precocious death 
of S, G2, and M cells is prevalent in these experimental con- 
ditions. This fact, and not a direct arrest in the G1 phase of 
the cell cycle, is, therefore, in our opinion the origin of the 
accumulation of 2c cells.  The function of the c-Jbs product 
may be considered essential to permit the survival of myeloid 
cells during differentiation. Leukemic myeloid blast cells can 
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Figure 8.  DNA fluorescence of PI-stained HL60 cells after 24 and 48 h 
of incubation under different experimental conditions. DNA histograms 
(log scale) of HL60 cells induced to differentiate with RA-DMSO in the 
presence of c-~s AS oligomer and treated with recombinant GM-CSF (A 
and B) and G-CSF (C and D) for 24 (left) and 48 h (right). 
survive for a long period of time in the peripheral blood with 
no significant proliferative activity and spontaneous differen- 
tiation  (49).  Our  data  suggest  the  possibility  that  this 
prolonged survival is in some way related to the sustained 
expression of the c-Jes protooncogene in these cells (12-14). 
The c-fis protooncogene might represent another example 
of an oncogene whose function is to prevent premature cell 
death. The function might therefore be similar,  in granulo- 
cytic cells, to that of the bcl-2 oncogene in pre-B cells (50, 
51). Support for this hypothesis comes from the observation 
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Figure 9.  Concentration response of IL-3, IL-6, SCF, G-CSF, and GM- 
CSF on the viability of HL60 cells. The cells were preincubated for 5 d 
with c-fis AS oligomer and then induced to differentiate with RA-DMSO 
in the presence of the same oligomer and the various cytokines as described 
in Materials  and Methods. 
AS 
[]-  AS+IL-3 
o  AS+Ib6 
[]  AS+SCF 
-  AS+GM-CSF 
o  AS+GCSF 
Table  3.  Effect of Different Growth Factors on the 2C/4C Ratio 
in HL60  Cells Treated with cfes AS  Oligomer and Differentiation 
Inducers 
Time  IL-3  IL-6  SCF  G-CSF  GM-CSF 
24  h  3,2  3,6  4  4,9  3,5 
48  h  12  13  10,8  4,2  5 
that the blast cells of promyelocytic leukemia are also sensi- 
tive to c-.~s AS oligomers when induced to differentiate with 
RA.  The possibility to induce programmed cell death of 
promyelocytic  cells during the early stages of induced granulo- 
cytic differentiation (52)  should therefore be explored. 
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